Teneligliptin hydrobromide hydrate is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients. It is principally a dipeptidyl peptidase-4 (DPP-4) inhibitor compound, commonly referred to as a gliptin, for the management of type 2 diabetes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Teneligliptin hydrobromide hydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Teneligliptin
pharmaceutical raw material
Teneligliptin hydrobromide
pharmaceutical raw material
Isopropyl cloprostenate
pharmaceutical raw material
Travoprost
pharmaceutical raw material
Rilzabrutinib, (Z)-
pharmaceutical raw material
Diroximel fumarate
pharmaceutical raw material
bis([(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone);hydrate;pentahydrobromide
NQPRXLXVOBOTGT-KSLCDFCZSA-N
CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5.O.Br.Br.Br.Br.Br
Sourcing Teneligliptin hydrobromide hydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.